Our team of dedicated, highly qualified specialists are focused on enhancing clinical success by closely proctoring and supporting the surgical teams in all phases of integrating the PlasmaJet into daily clinical practice.
We routinely conduct Product Training Workshops and Surgical MasterClasses throughout the USA and Europe. This training, along with peer-to-peer proctorship and hospital based clinical support, enhances a surgeon’s ability to expand the clinical utility of the product and effect positive patient outcomes.
Since late 2004, PlasmaJet has been used in thousands of operative cases by surgeons across North America and Europe. PlasmaJet’s efficacy and safety has been evaluated and described in over 70 scientific papers, abstracts, and posters.
Roman H., et al. (2014). Laparoscopic and transanal excision of large lower and mid-rectal deep endometriotic nodules: the Rouen technique. Fertility & Sterility;S0015-0282(14):00398- 7. (Video Article).
Madhuri, T.K., et al. (2010). Interim results from RCT to evaluate PlasmaJet® for prevention of lymphocyst formation following bilateral groin node dissection (BGND) for vulvar cancer. IGCS 13th Biennial Meeting, Prague. (Poster Presentation).
Nobbenhuis, M.A.E., et al. (2013). PlasmaJet® ablation and resection of carcinomatosis in ovarian cancer to achieve complete cytoreduction: initial experience. The Royal Marsden NHS Foundation Trust, London, United Kingdom. (Poster Presentation).
Roman H., et al. (2013). Postoperative recurrence and fertility following endometrioma ablation using plasma energy: retrospective assessment of a 3-year experience. J Minim Invasive Gynecol;20(5):573-582.